{
    "id": 25406,
    "fullName": "ANGPT1 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ANGPT1 positive indicates the presence of the ANGPT1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 284,
        "geneSymbol": "ANGPT1",
        "terms": [
            "ANGPT1",
            "AGP1",
            "AGPT",
            "ANG1"
        ]
    },
    "variant": "positive",
    "createDate": "09/20/2016",
    "updateDate": "01/02/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8424,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, AMG 780 treatment resulted in reduced tumor blood flow in 37.5% (6/16) and stable disease in 23% (8/35) of patients with advanced solid tumors, positive for Angpt1 and Angpt2 expression (PMID: 27076631).",
            "molecularProfile": {
                "id": 26320,
                "profileName": "ANGPT1 pos ANGPT2 pos"
            },
            "therapy": {
                "id": 4724,
                "therapyName": "AMG 780",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6651,
                    "pubMedId": 27076631,
                    "title": "A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27076631"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26319,
            "profileName": "ANGPT1 positive",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26320,
            "profileName": "ANGPT1 pos ANGPT2 pos",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}